Taha Kassim Dohadwala

5th Year Medical Student at David Tvildiani Medical University. Research Enthusiast.

[Yan Leyfman, MD @YLeyfman]

🚨 What if we could move beyond “watch and wait” and fundamentally rethink first-line therapy for indolent B-cell lymphomas?

Join us for the next episode of MedNews Week Medical Spotlight featuring Paolo Strati, one of the world's leading experts in lymphoma immunotherapy and cellular therapy.

Dr. Strati serves as:
• Deputy Section Chief for Indolent B-Cell Lymphomas
• CARTOX Program Leader
• Internationally recognized investigator in lymphoma therapeutics

In this masterclass, Dr. Strati will discuss the emerging role of AR² therapy and how novel treatment strategies are reshaping the frontline management of indolent B-cell lymphomas.

Topics include:
🔹 Evolution of first-line treatment paradigms
🔹 Clinical data supporting AR² therapy
🔹 Patient selection and practical implementation
🔹 Future directions in lymphoma care

Whether you're a hematologist, oncologist, trainee, advanced practitioner, researcher, or patient advocate, this is a discussion you won't want to miss.

📺 https://t.co/6XJO8y4DNN

#Lymphoma #Hematology #Oncology #Immunotherapy #CellTherapy #MedicalEducation #MedTwitter #HemOnc #CancerResearch #MDAnderson #BCellLymphoma @MedNewsWeek

[Yan Leyfman, MD @YLeyfman]

The future of cancer care isn’t about doing more—
it’s about doing less, with greater precision 💊🧬

In this MedNews Week Conference, Keynote Speaker Dr. Melvin L.K. Chua challenges how we think about treating nasopharyngeal carcinoma—shifting the focus toward intentional, evidence-based care 🧠

It’s easy to spotlight what’s new.

The real shift? Asking what actually improves outcomes 🚨

That’s the conversation we’re having here.

🎥 Watch the full episode:
👉 https://t.co/ozVCvzrMAH

#MedNewsWeek #Oncology #RadiationOncology #PrecisionMedicine #ProtonTherapy #CancerCare

[OncoDaily @oncodaily]

We are pleased to announce the collaboration between OncoDaily and MedNewsWeek.

This partnership marks an exciting step forward as we continue to shape the future of oncology and medicine worldwide.

🎬 Watch the first episode on OncoDaily on April 14 at 8:00 AM (GMT).

Together, we are creating a space that not only shares knowledge but also builds leaders, fosters global collaboration, and highlights talent from every corner of the world.

@YLeyfman @MedNewsWeek

#MedNewsWeek #OncoDaily #Oncology #MedicalEducation #GlobalHealth #HealthcareInnovation #CancerResearch

[Yan Leyfman, MD @YLeyfman]

MedNews Week is proud to announce our partnership with OncoDaily.

This collaboration marks an exciting step forward as we continue to expand our platform, amplify our mission, and elevate the voices shaping the future of oncology and medicine worldwide.

Together, we are creating a space that not only shares knowledge—but builds leaders, fosters global collaboration, and shines a light on talent across every corner of the world.

Our mission remains unchanged.

We are MedNews Week — connecting medicine, globally.

This is only the beginning.

The best is yet to come.

[Yan Leyfman, MD @YLeyfman]

🚨 New Publication Alert in Biomedicines! 🚨

🔗 https://t.co/ifFSoDzf2V

Today, I’m incredibly proud — not just of the science, but of the team behind it.

First and foremost, I want to recognize the MedNews Week team 💙🌍. Watching our trainees contribute meaningfully to scholarship — learning how to critically analyze data, write with precision, and think globally — is exactly why MNW exists. Mentorship is not a side project; it’s the mission. Seeing them grow into authors and future leaders in oncology is deeply fulfilling.

A special thank you to Dr. Chandler Park for his continued mentorship and guidance. Your leadership and belief in building globally minded physician-scholars continues to shape not only this work, but the trajectory of so many trainees.

We are also grateful to Dr. Jorge Eduardo Cortes for the invaluable insights he shared during our MedNews Week Keynote Conference. His keynote presentation and inspirational leadership in leukemia research remind us what academic excellence looks like — rigorous, innovative, and always patient-centered. It is truly a pleasure to learn from him.

📚 Manuscript Summary

This publication explores key advances reshaping modern hematology-oncology, focusing on how emerging biologic insights are translating into next-generation therapeutic strategies.

The manuscript highlights:

🧬 Evolving Disease Biology – A deeper understanding of molecular and immunologic mechanisms that refine risk stratification and personalize treatment decisions.

💊 Targeted & Immune-Based Therapies – How novel agents and immunomodulatory strategies are moving beyond legacy treatment paradigms toward more precise, biology-driven interventions.

📊 Data-Driven Precision Oncology – Integration of clinical, genomic, and translational data to inform smarter therapeutic sequencing and patient selection.

🌍 Global & Educational Impact – The importance of disseminating cutting-edge knowledge across borders to reduce inequities in access to innovation.

At its core, this paper reflects a simple but powerful goal:

Translate complexity into clarity — and science into better outcomes for patients.

Grateful to collaborate with brilliant minds, mentor future leaders, and continue pushing the field forward together. 🚀

#MedNewsWeek #Oncology #Hematology #TranslationalResearch #PrecisionMedicine #MedicalEducation @MDPIOpenAccess @MedNewsWeek @CParkMD @jorgecortesmd

[Taha Kassim Dohadwala @Tahu_09]

Grateful to the amazing team at @MedNewsWeek for the opportunity to author this manuscript under the mentorship of @YLeyfman!

[Yan Leyfman, MD @YLeyfman]

🚀 New Publication from @MedNewsWeek🚀

Incredibly proud of this group of trainees who stepped up to co-author this manuscript alongside Dr. Chandler Park.

This is what mentorship is supposed to look like —
🔥 challenge them
📚 elevate them
🎤 give them a platform
📈 watch them grow

At MedNews Week, we don’t just talk about developing future leaders in oncology — we actively build them. Seeing trainees move from learners to published authors is exactly why we do this.

Grateful to Ariana Pelosci for the opportunity to publish this important work in ONCOLOGY. We truly appreciate the platform to contribute to meaningful conversations shaping cancer care.

Now — let’s talk about the science. 🧬

This article dives into the evolving treatment landscape of multiple myeloma and why the conversation is more dynamic than ever:

🔬 ASCT still matters. Despite game-changing advances, autologous stem cell transplant remains a foundational strategy in frontline-eligible patients.

📊 Landmark trials (DETERMINATION, IFM 2009) reinforce deeper progression-free survival with early transplant — even in the era of modern induction regimens.

🧪 MRD is reshaping personalization. Minimal residual disease assessment is becoming critical in determining who benefits most and how we tailor therapy.

💉 CAR-T & bispecifics are redefining relapse. Cellular therapy and immune redirection strategies are revolutionizing refractory myeloma — and may change sequencing paradigms altogether.

⚖️ The big question: How do we optimally integrate transplant, cellular therapy, and precision approaches to maximize durability while minimizing toxicity?

That’s where oncology is headed.

The future isn’t just novel drugs.
It’s strategy.
It’s precision.
It’s training the next generation to think critically about integration.

And we’re all in. 💥

https://t.co/hmIBo0PnbG

#Oncology #MultipleMyeloma #CellTherapy #CAR_T #MedEd #NextGenLeadership @APelosci @CParkMD @CancerNetwrk @OncLive

[Yan Leyfman, MD @YLeyfman]

AI is already shaping clinical decisions.

Clinicians are barely being asked.

From notes and inboxes to triage and decision support, AI is entering medicine faster than guidance, policy, or oversight.

We’re collecting real frontline clinician experiences with AI:

• What actually helps patient care

• What adds risk or cognitive burden

• Where safeguards and standards are missing

⏱️ Takes 5 minutes

🔒 Anonymous

🌍 Open to all specialties, roles, and training levels

This isn’t about hype.

It’s about protecting patient safety, clinical judgment, and physician autonomy as AI scales.

If clinicians don’t define the evidence, others will.

👉 Add your voice here:

https://t.co/AIuUYcwK6s

🙏 Please reshare — collective data is how we influence policy, practice, and trust.

[Yan Leyfman, MD @YLeyfman]

📣How are you actually using AI in practice?📣

We’re running a very short, anonymous survey (⏱️ 5 minutes) looking at real-world AI use in medicine — from documentation to clinical decision-making.

✅ Any training level

✅ Any practice setting

✅ Whether you use AI daily, occasionally, or not at all

✅ Includes a brief clinical scenario

Your perspective matters — especially as AI tools are increasingly part of our workflows.

👉 Take the survey here: https://t.co/AIuUYcwK6s

🙏 Please share with colleagues — broader input = better insights.

Thank you.

#AIinMedicine #DigitalHealth #AIinHealthcare #ClinicalPractice #PhysicianVoices

[Arturo LoAIza-Bonilla, MD MSEd @DrArturoAI]

A great honor, thank you for this wonderful recognition, MedNews Week !! Always happy to contribute to the professional development of those eager to keep advancing science and innovation in oncology!!

@mystlukes @ASCO @MassiveBio @CancerXMoonshot @AmericanCancer

[Yan Leyfman, MD @YLeyfman]

This month marks the 4-year anniversary of MedNews Week. Four years since a simple idea in December 2021 grew into our first episode in January 2022. What started with three people and one mission has become a global movement in medical education, reaching thousands of clinicians and patients at every episode, and a team of over 35 volunteers who pour their hearts, time, and passion into this platform.

Today, we are humbled and honored that our work has been officially published in the prestigious Journal of Global Oncology (JCO) Global Oncology. For our initiative to be showcased on a global academic stage is not just a milestone—it is validation that free, accessible education makes a difference, and that innovation and equity can be created anywhere when enough people believe in a mission.

None of this happened alone.

To the MedNews Week team:
Thank you. You are the soul of this platform. Watching each member grow, lead, and realize their potential has been the greatest privilege of all. This community exists because you kept showing up and kept moving the mission forward.

To our speakers:
Thank you for giving your time, expertise, and energy—not for recognition, but because you care about the impact your words can have on patients, clinicians, and families across the world. You helped shape a global classroom.

To ASCO and Conquer Cancer:
Thank you for believing in us when we were still growing. Our journey with ASCO Breakthrough 2023 and the opportunity to present this work in Japan was transformative. A heartfelt thank you to Dr. Julie Gralow and the ASCO team for your support, generosity, and mentorship. We are forever grateful.

To our partners:
Thank you for embracing this mission. Thank you for celebrating innovation in education and entrusting us with your audiences, your time, and your belief that we all share a responsibility to lift this field higher.

And to the people who helped guide us here:
Dr. Chandler Park — thank you for helping build this vision from day one.
Dr. Arturo Bonilla — thank you for your mentorship, guidance, and belief in what this platform could become.

MedNews Week was built for one purpose:
To combat global healthcare misinformation and democratize medical education—regardless of geography, background, or financial barriers.

Today we reach over 100 countries, including 44 lower-income regions. We have featured world leaders in medicine, we have become a platform for global conversation and collaboration, and we are just getting started.

From the bottom of my heart:
Thank you to every speaker, every attendee, every partner, every team member, every person who believed in us. Thank you for letting this platform become a community. Thank you for helping us build something that makes medicine more accessible, more human, and more equitable.

We are proud, we are humbled, and we are excited for what comes next.

Here’s to the first four years—and to all the impact still ahead.

manuscript link: https://t.co/XPEX64duwN

[Yan Leyfman, MD @YLeyfman]

🔥 MedNews Week x OncLive | Keynote Conference 🔥

Featuring the trailblazing breast oncology leader: Dr. Sara Hurvitz, MD, FACP

Get ready — our next Keynote Conference spotlights one of the most influential minds in modern oncology.

Dr. Sara A. Hurvitz is not only a world-renowned breast cancer expert, but a visionary researcher, award-winning clinician, and transformative mentor whose work continues to shape the future of cancer care.

And now, she joins us to tackle one of the biggest questions in breast oncology today:

💥 Is it time to rethink the routine use of anthracyclines?

💥 What does the modern era of breast cancer treatment really demand?

🚀 Join us for a keynote that challenges convention, inspires innovation, and elevates the conversation around breast cancer treatment.

This is THE session you’ll be talking about long after it ends.

Presentation link: https://t.co/eAfytKCvtZ

#Oncology #BreastCancer #MedicalEducation #CancerResearch #MedNewsWeek #OncLive #ClinicalTrials #WomenInMedicine #InnovationInMedicine #HemeOnc #CancerCare #PrecisionOncology

Fred Hutch University of Washington - School of Medicine

[Yan Leyfman, MD @YLeyfman]

🔥 MedNews Week x OncLive | Keynote Conference 🔥
Featuring the trailblazing breast oncology leader: Dr. Sara A. Hurvitz, MD, FACP

Get ready — our next Keynote Conference spotlights one of the most influential minds in modern oncology.

Dr. Sara A. Hurvitz is not only a world-renowned breast cancer expert, but a visionary researcher, award-winning clinician, and transformative mentor whose work continues to shape the future of cancer care.

And now, she joins us to tackle one of the biggest questions in breast oncology today:

💥 Is it time to rethink the routine use of anthracyclines?

💥 What does the modern era of breast cancer treatment really demand?

🚀 Join us for a keynote that challenges convention, inspires innovation, and elevates the conversation around breast cancer treatment.

This is THE session you’ll be talking about long after it ends.

Presentation link:
https://t.co/eAfytKCvtZ

#Oncology #BreastCancer #MedicalEducation #CancerResearch #MedNewsWeek #OncLive #ClinicalTrials #WomenInMedicine #InnovationInMedicine #HemeOnc #CancerCare #PrecisionOncology @MedNewsWeek

[Yan Leyfman, MD @YLeyfman]

🎉 Huge congratulations to the MedNews Week team on our latest publication! I’m incredibly proud of everyone for their hard work, passion, and dedication that made this possible.

A special thank you to Dr. Seth M. Pollack for your inspirational keynote presentation, and to Dr. Chandler Park for your invaluable mentorship and guidance.

We’re also deeply grateful to @CancerNetwrk, @APelosci, and @DrJulieVose for their continued support and mentorship. Together, we’re making a difference in the oncology community! 💪🩺✨

#Oncology #MedicalEducation #Teamwork #Leadership #MedNewsWeek @immunosarc @CParkMD @MedNewsWeek

[Taha Kassim Dohadwala @Tahu_09]

We would like to thank our amazing team @vivi_medonc, @Jenna_ghazal_, @HarshithaValla, @AhmedHashimAZ and @kennedyeureka1 and to our mentors @YLeyfman @CParkMD for their guidance.

And thank you to @CancerNetwrk, especially @APelosci and @DrJulieVose, for their collaboration.

[Taha Kassim Dohadwala @Tahu_09]

Proud to present our latest @MedNewsWeek publication, “Immune Modulation in Sarcoma: Targeting the Tumor Microenvironment” a collaborative effort with Dr. Seth M. Pollack @immunosarc!

📖: https://t.co/ErX9ruP0JC

[Taha Kassim Dohadwala @Tahu_09]

Sarcoma therapy is entering a new era. By reprogramming the tumor microenvironment and targeting macrophages, new strategies like TLR4 agonists, CTA-targeted TCRs, and even canine CAR T models are paving the way for more precise and durable cancer treatments.

[Rithika.SK3 @RithikaSk3]

How much can great mentorship shape your medical journey? 🌟

In this OncLive session, Dr. Ann LaCasce & Dr. Judith Trotman share insights on growth, guidance, and finding your path in medicine.

🔗https://t.co/RsOUSieGjS

[Aishwarya Singh @aishwar39203461]

Wondering what’s driving the future of #medical careers?
Watch the latest @MedNewsWeek x @OncLive episode where Dr. Ann LaCasce & Dr. Judith Trotman explore the journey of #CareerGrowth, leadership, lifelong learning, and mentorship in #medicine

🔗https://t.co/MK2vdyDdyf

[Kennedyeureka1 @kennedyeureka1]

Don't miss Dr. Ann LaCasce and Dr.Judith Trotman's inspiring discussion on mentorship, leadership, and lifelong learning hosted by @MedNewsWeek & @OncLive get an enlightening perspective on how this is shaping the future of medical careers!

Event link: https://t.co/rc0EWs1tEA

[Yan Leyfman, MD @YLeyfman]

Extremely proud of our MedNews Week team and their hard work to make this important piece a reality. Thank you so much to Global Oncology Leader Dr. Amer Zeidan of Yale School of Medicine for your great mentorship and continued support.

@Dr_AmerZeidan @YaleMed @Yale @MedNewsWeek